Serotype Distribution of Chest X-ray Confirmed Pneumococcal Community Acquired Pneumonia in the Adult Population in Greece, Over 1 Year. (B1851065)
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Detailed Description
Study Type
Study Type
Enrollment (Actual)
Enrollment
Contacts and Locations
Study Locations
-
-
-
Alexandroupoli, Greece, 68100
- General University Hospital of Alexandroupoli
-
Athens, Greece, 11527
- General Chest Diseases Hospital "Sotiria"/ 7th Department of Pulmonary Medicine
-
Athens, Greece, 11527
- General Hospital of Athens "Sotiria"/ 12Th Pneumonology Clinic
-
Athens, Greece, 11527
- General Hospital of Athens "Sotiria"/ 1St Pneumonology Clinic
-
Athens, Greece, 11527
- General Hospital of Athens "Sotiria"/ 2Nd Pneumonology Clinic
-
Athens, Greece, 11527
- General Hospital of Athens "Sotiria"/ 5Th Pneumonology Clinic
-
Athens, Greece, 11527
- General Hospital of Athens "Sotiria"/ 6Th Pneumonology Clinic
-
Athens, Greece, 11527
- General Hospital of Athens "Sotiria"/ 8Th Pneumonology Clinic
-
Athens, Greece, 15123
- Diagnostic Therapeutic Center of Athens Ygeia
-
Athens, Greece, 15126
- General Hospital Athens "Sismanoglio"/ 1St Pneumonology Clinic
-
Athens, Greece, 15126
- General Hospital of Athens "Sismanoglio" / 3Rd Pneumonology Department
-
Athens, Greece, 15126
- General Hospital of Athens "Sismanoglio"/ 2Nd Pneumonology Clinic
-
Athens, Greece, 15127
- General Hospital Mellision "Amalia Fleming"/ Pneumonology Clinic
-
Athens, Greece, 15127
- General Hospital Mellision "Amalia Fleming"/2nd Internal Medicine Department
-
Athens, Greece, 15227
- Sotiria Hospital, Intensive Care Unit
-
Athnens, Greece
- General University Hospital "Attikgeneral University Hospital "Attikon"/ 4Th University Internal Med
-
Kavala, Greece, 65201
- General Hospital of Kavala/ A Pneumonological Clinic
-
Kavala, Greece, 65201
- General Hospital of Kavala/ b Pneumonological & Tubeculosis Department
-
Larissa, Greece, 41 110
- University General Hospial of Larissa, Pneumonology Department
-
-
Attiki
-
Athens, Attiki, Greece
- General Hospital of Athens "Evangelismos" / Pneumonology Department
-
-
Evros
-
Alexandroupoli, Evros, Greece, 68100
- University Hospital of Alexandroupolis
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Patients who agreed to participate in the study and agreed to sign an ICD.
- Patients had to be ≥18 years of age (adults)
- Patients had to present or had been referred to a participating healthcare facility with suspected pneumonia based on the physician's assessment (including but not limited to specific signs and symptoms described in Section 9.3 of the protocol)
- Patients must have had a posteroanterior or anteroposterior chest X-ray showing an infiltrate (if previous films were not available) or a new infiltrate (if recent film was available)
- Patients had to be tested positive for the Binax NOW® assay (required post Protocol Amendment 2)
Exclusion Criteria:
- Patients who did not sign an ICD.
- Any patient who developed signs and symptoms of pneumonia after being hospitalized for ≥48 hours
- Any patient who was transferred to a study healthcare facility after already being hospitalized for ≥48 hours at another healthcare facility
- Patients who did not have a chest X-ray performed
- Patients who did not have the Binax NOW® assay performed
- Patients with negative results for the Binax NOW® assay (required post Protocol Amendment 2)
Study Plan
How is the study designed?
Design Details
- Observational Models: Case-Only
- Time Perspectives: Prospective
Number of groups / cohorts
Cohorts and Interventions
Group / CohortGroup / Cohort |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Group one
Adults ≥18 years of age with chest X-ray confirmed CAP
|
This Is A Non Interventional Study
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
The frequency of serotypes 4,6B,9V,14,18C,19F,23F,1,3,5,6A,7F and 19A from chest X-ray confirmed pCAP patients (post amendment2 with positive Binax NOW® only) who presented in the emergency departments of 15 hospitals in Greece during 1
Time Frame: One year
|
One year
|
|
calendar year.
Time Frame: One year
|
One year
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Susceptibility, resistance or partial resistance Streptococcus pneumoniae clinical isolates obtained from study adult CAP patients.
Time Frame: One year
|
One year
|
|
The frequency of the 4, 6B, 9V, 14, 18C, 19F, 23F, 1, 3, 5, 6A, 7F, 19A serotypes (based on Luminex assay) of study patients immunized and not immunized with PPV.
Time Frame: One year
|
One year
|
Collaborators and Investigators
Sponsor
Sponsor
Study record dates
Study Major Dates
Study Start
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Actual)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Estimate)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- B1851065
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.